ELUTIA INC. (ELUT) Executive Compensation
ELUTIA INC. (ELUT) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ELUT
CIK: 1708527
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerAlexander Raymond
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-14 | 2026-09-10 | 4 Filing | 0001398249-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 Filing | 0001304079-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 Filing | 0001370939-26-000011 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-17 | 8-K | 0001104659-26-099731 | View SEC Doc Filr Page |
| S-8 | 2026-08-14 | — | FORM S-8 | 0001104659-26-097329 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-097292 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-096804 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001104659-26-095934 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-11 | — | SCHEDULE 13G Filing | 0001104659-26-093849 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-06 | FORM 8-K | 0001104659-26-092718 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-16 | FORM 8-K | 0001104659-26-085061 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-21 | 4 Filing | 0001370939-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-11 | 8-K | 0001104659-26-074660 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001184421-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001818776-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001222362-26-000013 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001375927-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001398249-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001304079-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001370939-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-06-01 | OWNERSHIP DOCUMENT | 0001104659-26-069476 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001104659-26-062634 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001104659-26-061150 | View SEC Doc Filr Page |
| ARS | 2026-04-22 | 2025-12-31 | ARS | 0001104659-26-046902 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-22 | — | DEFA14A | 0001104659-26-046901 | View SEC Doc Filr Page |